RXi Pharmaceuticals Corp

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Bolsters Protection for its Novel Self-Delivering RNAi Platform with Notice of Allowance from USPTO

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced that …

Corey Williams — October 5, 2015, 7:07 AM EDT

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Granted Patent in China for Lead Clinical Candidate RXI-109

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced that …

Corey Williams — September 28, 2015, 12:25 PM EDT

Biotech Beat: RXi Pharmaceuticals Corp (RXII), ACADIA Pharmaceuticals Inc. (ACAD), Valeant Pharmaceuticals Intl Inc (VRX)

By Terry Chrisomalis RXi Pharmaceuticals Corp On August 31, 2015 RXi Pharmaceuticals Corp (NASDAQ:RXII) announced that the 30-day review period for its IND of RXI-109 …

CNA Finance CNA Finance — September 8, 2015, 5:14 PM EDT

RXi Pharmaceuticals Corp Represents An Underappreciated Innovator With Upside Potential: H.C. Wainwright

In a research report issued today, H.C.

Jason Cohen Jason Cohen — September 1, 2015, 11:32 AM EDT

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces Advancements in its Ophthalmology Clinical Program with RXI-109

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced …

Corey Williams — August 31, 2015, 9:04 AM EDT

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Reports 2Q:15 Financial Results and Business Highlights

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapeutics primarily in the areas of dermatology and ophthalmology, today reported …

Corey Williams — August 12, 2015, 7:35 AM EDT

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Strengthens Intellectual Property Portfolio for Novel RNAi Platform

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, announced …

Corey Williams — June 9, 2015, 7:10 AM EDT

Company Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, announced …

Corey Williams — June 3, 2015, 7:16 AM EDT

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces $10 Million Public Offering of Common Stock and Warrants

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, announced …

Corey Williams — May 28, 2015, 7:08 AM EDT

Stock Update (NASDAQ:RXII): RXi Pharmaceuticals Corp Announces Proposed Public Offering of Common Stock and Warrants

RXi Pharmaceuticals Corp (NASDAQ:RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, today announced that …

Corey Williams — May 27, 2015, 4:17 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts